<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38237983</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0814</ISSN><JournalIssue CitedMedium="Internet"><Volume>202</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Progress in molecular biology and translational science</Title><ISOAbbreviation>Prog Mol Biol Transl Sci</ISOAbbreviation></Journal><ArticleTitle>Long Covid.</ArticleTitle><Pagination><StartPage>113</StartPage><EndPage>125</EndPage><MedlinePgn>113-125</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/bs.pmbts.2023.11.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1877-1173(23)00177-1</ELocationID><Abstract><AbstractText>Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), refers to a constellation of persistent symptoms and health issues that continue beyond the acute phase of COVID-19. This chapter provides an overview of the pathogenesis, risk factors, manifestations, major findings, and diagnosis and treatment strategies associated with Long COVID. Hypotheses regarding the pathogenesis of Long COVID are discussed, encompassing various factors such as persistent viral reservoirs, immune dysregulation with or without reactivation of herpesviruses (e.g., Epstein-Barr Virus and human herpesvirus), dysbiosis, autoimmunity triggered by infection, endothelial dysfunction, microvessel blood clotting, and dysfunctional brainstem and/or vagal signaling. The chapter also highlights the risk factors associated with Long COVID and its occurrence in children. The major findings of Long COVID, including immune dysregulation, vessel and tissue damage, neurological and cognitive pathology, eye symptoms, endocrinal issues, myalgic encephalomyelitis and chronic fatigue syndrome, reproductive system involvement, respiratory and gastrointestinal symptoms, and the chronology of symptoms, are thoroughly explored. Lastly, the chapter discusses the challenges and current approaches in the diagnosis and treatment of Long COVID, emphasizing the need for multidisciplinary care and individualized management strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zaidi</LastName><ForeName>Asiya Kamber</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>ENT Surgeon and Research Fellow, Associazione Naso Sano, Italy. Electronic address: asiyazaidia@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dehgani-Mobaraki</LastName><ForeName>Puya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Founder and President, Associazione Naso Sano, Ringgold Institution ID 567754, San Mariano, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Prog Mol Biol Transl Sci</MedlineTA><NlmUniqueID>101498165</NlmUniqueID><ISSNLinking>1877-1173</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020031" MajorTopicYN="Y">Epstein-Barr Virus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004854" MajorTopicYN="N">Herpesvirus 4, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long Covid</Keyword><Keyword MajorTopicYN="N">Long haulers</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 persistence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>19</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>18</Day><Hour>20</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38237983</ArticleId><ArticleId IdType="doi">10.1016/bs.pmbts.2023.11.002</ArticleId><ArticleId IdType="pii">S1877-1173(23)00177-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>